Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket Capitalization

KalVista Pharmaceuticals (KALV) Debt to Equity: 2014-2016

Historic Debt to Equity for KalVista Pharmaceuticals (KALV) over the last 1 years, with Mar 2016 value amounting to $0.11.

  • KalVista Pharmaceuticals' Debt to Equity rose 218.06% to $0.11 in Q1 2016 from the same period last year, while for Mar 2016 it was $0.11, marking a year-over-year increase of 218.06%. This contributed to the annual value of -$0.00 for FY2016, which is N/A change from last year.
  • According to the latest figures from Q1 2016, KalVista Pharmaceuticals' Debt to Equity is $0.11, which was up 15.53% from $0.09 recorded in Q4 2015.
  • KalVista Pharmaceuticals' 5-year Debt to Equity high stood at $0.11 for Q1 2016, and its period low was -$0.10 during Q4 2014.
  • Over the past 3 years, KalVista Pharmaceuticals' median Debt to Equity value was $0.08 (recorded in 2015), while the average stood at $0.03.
  • Data for KalVista Pharmaceuticals' Debt to Equity shows a peak YoY spiked of 218.06% (in 2016) over the last 5 years.
  • Over the past 3 years, KalVista Pharmaceuticals' Debt to Equity (Quarterly) stood at -$0.10 in 2014, then skyrocketed by 193.11% to $0.09 in 2015, then spiked by 218.06% to $0.11 in 2016.
  • Its Debt to Equity stands at $0.11 for Q1 2016, versus $0.09 for Q4 2015 and $0.08 for Q3 2015.